Table 2 Cerebellar volume and psychiatric outcome in VLBW participants and controls
| Â | Assessed at 15Â years | Assessed 19 at years | ||
|---|---|---|---|---|
VLBW (NÂ =Â 40) | Control (NÂ =Â 56) | VLBW (NÂ =Â 44) | Control (NÂ =Â 60) | |
Cerebellar volume (ml) M (SD) | ||||
 White matter M (SD) | 25.52 (4.05)* | 28.93 (3.04) | 26.60 (4.03)* | 29.83 (3.10) |
 Gray matter M (SD) | 99.46 (11.02) | 103.93 (10.08) | 96.59 (11.14) | 103.57 (8.85) |
Psychiatric questionnaires | ||||
 CGAS M (SD) | 71.73 (14.48)*** | 86.96 (6.75) | 79.05 (12.75)** | 85.78 (7.69) |
 ASEBA M (SD) | ||||
  Internalizing M (SD) | 6.95 (5.27) | 7.23 (5.96) | 10.00 (9.45) | 7.33 (7.25) |
  Externalizing M (SD) | 7.68 (4.74) | 8.14 (5.84) | 7.25 (4.99) | 6.48 (5.78) |
  Total problems. M (SD) | 25.16 (14.91) | 24.59 (15.81) | 32.15 (21.53) | 26.90 (20.78) |
 ADHD-RS-IV | ||||
  Hyperactivity M (SD) | 2.78 (3.71) | 1.43 (1.78) | 2.90 (4.29) | 1.34 (1.67) |
  Inattention M (SD) | 6.39 (5.11)*** | 2.51 (2.81) | 5.45 (5.58)** | 1.76 (1.98) |
Clinical diagnoses | ||||
 Any psychiatric diagnosis M (SD) | 12 (30)** | 3 (5.36) | 11 (25)** | 4 (6.67) |
  Anxiety disorders M (SD) | 5 (12.50) | 2 (3.57) | 7 (15.91)** | 1 (1.67) |
  ADHD M (SD) | 3 (7.50)* | 0 (0) | 4 (9.09)* | 0 (0) |
  Other M (SD) | 4 (10) | 1 (1.76) | 0 (0) | 3 (5) |
 Any subclinical diagnosis n (%) | 11 (27.50)*** | 1 (1.76) | 5 (11.36) | 6 (10) |
  Anxiety n (%) | 3 (7.50) | 1 (1.76) | 4 (9.09) | 2 (3.33) |
 ADHD n (%) | 8 (20)*** | 0 (0) | 1 (2.27) | 3 (5) |
  Other n (%) | 0 (0) | 0 (0) | 0 (0) | 1 (1.67) |
 Diagnostic status n (%) | ||||
  Healthy/became healthy n (%) | 22 (55)** | 46 (82) | 25 (57)** | 50 (83) |
  Persisting/developed diagnosis n (%) | 18 (45)** | 10 (18) | 16 (36)* | 9 (15) |